Brief: Heron Therapeutics Announces Partnership With Crosslink Life Sciences To Expand Promotional Effort For Zynrelef®, First And Only Non-Opioid Dual Acting Local Anesthetic For Post-Operative Pain
Jan 7 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS ANNOUNCES PARTNERSHIP WITH CROSSLINK
LIFE
SCIENCES TO EXPAND PROMOTIONAL EFFORT FOR ZYNRELEF®, FIRST AND
ONLY NON-OPIOID DUAL ACTING LOCAL ANESTHETIC FOR POST-OPERATIVE
PAIN
Source text for Eikon: ID:nPn3sYDG1a
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop